M. Kulyk & Associates, LLC Pfizer Inc Transaction History

M. Kulyk & Associates, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $15,820 - $18,492	-493 Reduced 6.34%	7,286 $241,000
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $11,857 - $15,478	284 Added 3.79%	7,779 $398,000
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $131 - $160	3 Added 0.04%	7,495 $328,000
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $20,845 - $24,716	-448 Reduced 5.64%	7,492 $393,000
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $61,533 - $76,248	1,345 Added 20.39%	7,940 $411,000
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $272,505 - $403,943	6,595 New	6,595 $389,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on M. Kulyk & Associates, LLC with notifications on news.